Table 3.
CLSI1 Class | Antimicrobial agents | Antimicrobial concentration range (µg/mL) | MIC2 interpretive criteria (µg/mL) |
||
---|---|---|---|---|---|
Susceptible | Resistance | Reference source | |||
Macrolides | AZI | 0.015-64 | ≤0.25 | ≥0.5 | NARMS3 |
ERY | 0.03-64 | ≤4 | ≥8 | NARMS | |
Lincosamides | CLI | 0.03-16 | ≤0.5 | ≥1 | NARMS |
Aminoglycosides | GEN | 0.25-32 | ≤2 | ≥4 | NARMS |
Quinolones | CIP | 0.015-64 | ≤0.5 | ≥1 | NARMS |
NAL | 4-64 | ≤16 | ≥32 | NARMS | |
Tetracyclines | TET | 0.06-64 | ≤1 | ≥2 | NARMS |
Phenicol | FLO | 0.03-64 | ≤4 | ≥8 | NARMS |
Abbreviations: AZI, azithromycin; CIP, ciprofloxacin; CM, clindamycin; ERY, erythromycin; FLO, florfenicol; GEN, gentamycin; NAL, nalidixic acid; TET, tetracycline.
Clinical and Laboratory Standards Institute.
Minimum Inhibatory Concentration.
National Antimicrobial Resistance Monitoring System.